CV Sciences (CVSI) Depreciation and Depletion (2015 - 2018)
CV Sciences (CVSI) reported Depreciation and Depletion of $150879.0 for Q4 2018, up 415.72% on a YoY basis from $29256.0 in Q4 2017, and up 23.76% sequentially from $121911.0 in Q3 2018.
CV Sciences (CVSI) Depreciation and Depletion (2015 - 2018) Analysis & Trends
CV Sciences (CVSI) has 4 years of Depreciation and Depletion data on file, last reported at $150879.0 in Q4 2018.
- For the quarter ending Q4 2018, Depreciation and Depletion rose 415.72% year-over-year to $150879.0; the trailing twelve-month figure through Dec 2018 stood at $500000.0 (up 240.14% YoY), and the FY2025 full-year result was $200000.0, down 33.33% from the prior year.
- Depreciation and Depletion grew to $150879.0 in Q4 2018, from $121911.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $150879.0 in Q4 2018 to a low of $29256.0 in Q4 2017.
- A 4-year average of $64531.3 and a median of $48833.5 in 2016 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion sank 39.65% in 2017 and surged 415.72% in 2018, its largest moves.
- Tracing CVSI's Depreciation and Depletion over 4 years: stood at $49113.0 in 2015, then declined by 1.3% to $48475.0 in 2016, then slumped by 39.65% to $29256.0 in 2017, then surged by 415.72% to $150879.0 in 2018.
- Business Quant data shows CVSI's Depreciation and Depletion at $150879.0 in Q4 2018, $121911.0 in Q3 2018, and $117014.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 150,879.00 |
| Dec 31, 2018 | 150,879.00 |
| Sep 30, 2018 | 121,911.00 |
| Sep 30, 2018 | 121,911.00 |
| Jun 30, 2018 | 117,014.00 |
| Jun 30, 2018 | 117,014.00 |
| Mar 31, 2018 | 110,196.00 |
| Mar 31, 2018 | 110,196.00 |
| Dec 31, 2017 | 29,256.00 |
| Dec 31, 2017 | 29,256.00 |
| Sep 30, 2017 | 30,897.00 |
| Sep 30, 2017 | 30,897.00 |
| Jun 30, 2017 | 39,322.00 |
| Jun 30, 2017 | 39,322.00 |
| Mar 31, 2017 | 47,525.00 |
| Mar 31, 2017 | 47,525.00 |
| Dec 31, 2016 | 48,475.00 |
| Dec 31, 2016 | 48,475.00 |
| Sep 30, 2016 | 48,977.00 |
| Sep 30, 2016 | 48,977.00 |